Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
Singal AK, Fontana RJ.
Aliment Pharmacol Ther · meta-analysis; journal article · DOI 10.1111/j.1365-2036.2011.04990.x PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för telbivudine. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
13 hitsInhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.
Nan XP, Zhang Y, Yu HT, Sun RL, Peng MJ, Li Y, Su WJ, Lian JQ, Wang JP, Bai XF.
Viral Immunol · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1089/vim.2011.0049Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases.
Brown JA, Pack LR, Fowler JD, Suo Z.
Chem Res Toxicol · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1021/tx200458sA comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.
Tsai MC, Lee CM, Chiu KW, Hung CH, Tung WC, Chen CH, Tseng PL, Chang KC, Wang JH, Lu SN, Yen YH, Hu TH.
J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkr495Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients.
Shi TD, Zhang JM, Wang XF, Chen M, Sun H, Chen CB, Ren H.
Clin Exp Med · research support, non-u.s. gov't; journal article · DOI 10.1007/s10238-011-0151-8Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis.
Dang S, Gao N, Zhang X, Jia X.
Am J Med Sci · research support, non-u.s. gov't; journal article; case reports · DOI 10.1097/maj.0b013e31821a520eCost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B.
Wiens A, Venson R, Correr CJ, Pontarolo R.
Braz J Infect Dis · comparative study; review; journal article · DOI 10.1016/s1413-8670(11)70180-5A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX.
J Hepatol · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/j.jhep.2011.02.032Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.
Gane EJ, Wang Y, Liaw YF, Hou J, Thongsawat S, Wan M, Moon YM, Jia J, Chao YC, Niu J, Leung N, Samuel D, Hsu CW, Bao W, Lopez P, Avila C.
Liver Int · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1478-3231.2011.02490.x[Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients].
Huang J, Chen XP, Chen XF, Chen WL, Chen R, Ma XJ, Luo XD.
Zhonghua Gan Zang Bing Za Zhi · randomized controlled trial; journal article · DOI 10.3760/cma.j.issn.1007-3418.2011.03.007Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine.
Zou XJ, Jiang XQ, Tian DY.
J Viral Hepat · journal article · DOI 10.1111/j.1365-2893.2010.01412.xSignificance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome.
Seto WK, Lai CL, Fung J, Wong DK, Yuen JC, Hung IF, Yuen MF.
J Hepatol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jhep.2010.11.018Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
Safadi R, Xie Q, Chen Y, Yin YK, Wei L, Hwang SG, Zuckerman E, Jia JD, Lopez P.
Liver Int · clinical trial, phase ii; comparative study; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1478-3231.2010.02360.x